PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cancer's game of hide-and-seek

Researchers describe a novel mechanism by which glioblastoma tumors resist targeted therapies

2013-12-06
(Press-News.org) Contact information: Rachel Steinhardt
rsteinhardt@licr.org
212-450-1582
Ludwig Institute for Cancer Research
Cancer's game of hide-and-seek Researchers describe a novel mechanism by which glioblastoma tumors resist targeted therapies December 5, 2013, New York, NY– A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which glioblastoma (GBM), the most common kind of brain cancer, evades targeted therapies. Published in the current issue of the journal Science, the paper describes how GBM tumor cells essentially hide the signaling molecule targeted by such therapies, adding a layer of complexity to current models of drug resistance in cancer. The findings could have far-reaching implications for the therapeutic regimens currently employed to treat GBM and suggest alternative approaches that could improve outcomes for cancer patients.

GBM tumors typically carry mutant forms of the EGF receptor. The gene for the most common of these mutant receptors, EGFRvIII, lies on small fragments of DNA known as double minute chromosomes and promotes uncontrolled cell proliferation. "You would expect that drugs that block EGF receptor signaling would devastate GBM tumors," says Paul Mischel, MD, Ludwig scientist based at the University of California, San Diego School of Medicine. Mischel led the multi-institutional study in close collaboration with Ludwig colleagues Web Cavenee, PhD, and Frank Furnari, PhD. "Yet such targeted drugs have not worked in GBM, and that has raised some serious questions among cancer researchers."

Only about 60 percent of cells express the aberrant receptor. To probe how this heterogeneity contributes to drug resistance, Mischel and his colleagues treated tumors taken from patients with targeted therapies. They found, to their surprise, that this prompted GBM cells to almost completely shut down their expression of EGFRvIII. But were the two cell types this yielded—those that expressed the EGFRvIII mutant, and those that did not—equally cancerous?

The answer: An unequivocal yes. The findings showed that GBM tumors don't survive targeted therapy by replacing susceptible cells with mutants unaffected by the drugs in question—a classical mechanism of resistance—but by hiding the target of those drugs. And they did this, surprisingly, by depleting the double minute chromosomes themselves. "Those DNA double minutes seem to hide out in a reservoir," says Mischel, "and when the drug is removed, the tumors come screaming back. When they return, the cells become susceptible once again to targeted therapy."

"Our research might have significant implications for how we dose patients," says Mischel. "A high-dose regimen of EGF receptor-targeting drugs, given in pulses, might be more effective than the continuous, lower-dose regimen employed today. That is a study that needs to be done."

The findings also amend a second prevailing model of drug resistance in cancer. Double minute chromosomes are thought to contribute to drug resistance mainly by encoding multiple copies of proteins that detoxify chemotherapy or drive cancer in other ways. But in GBM, tumors actually shut down a cancer-promoting gene to evade drug targeting. "Many kinds of tumors have extra-chromosomal DNA fragments that carry cancer-promoting genes," says Mischel. "So this new mechanism could be a far more common phenomenon in cancer than we've realized."

Mischel and his colleagues are now exploring that possibility.

### Funding support for this research was provided by the Ludwig Institute for Cancer Research; the Ben and Catherine Ivy Foundation Fund; the National Institutes of Health (NIH); the Ziering Family Foundation in memory of Sigi Ziering (T.F.C. and P.S.M.); Art of the Brain Fund (T.F.C.); the James S. McDonnell Foundation (to F.B.F); the European Commission; Ruth L. Kirschstein Institutional National Research Service Award; and the UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program (D.A.N).

About Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists with a 40-year legacy of pioneering cancer discoveries. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $1.6 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers. http://www.ludwigcancerresearch.org

Paul Mischel is a member of the Ludwig Institute for Cancer Research and a professor in the department of pathology at the UC San Diego School of Medicine.

For further information please contact Rachel Steinhardt, rsteinhardt@licr.org or +1-212-450-1582.


ELSE PRESS RELEASES FROM THIS DATE:

Scientists calculate friction of Japan's 9.0 earthquake in 2011

2013-12-06
Scientists calculate friction of Japan's 9.0 earthquake in 2011 CORVALLIS, Ore. – An international team of scientists that installed a borehole temperature observatory following the 2011 Tohoku-Oki earthquake in Japan has been able to measure the "frictional ...

Cancer mutation likely trigger of scleroderma

2013-12-06
Cancer mutation likely trigger of scleroderma Findings could reshape research on cancer origins and treatment of other autoimmune diseases Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and ...

7 world-class cities riding tall in bike-share boom, solving 'the last mile' without cars

2013-12-06
PUBLIC RELEASE DATE: 5-Dec-2013 [ | E-mail ] var addthis_pub="eurekalert"; var addthis_options = "favorites, delicious, digg, facebook, twitter, google, newsvine, reddit, slashdot, stumbleupon, buzz, more" Share Contact: Jemilah Magnusson jemilah.magnusson@itdp.org 646-380-2357 Dan Klotz dklotz@burnesscommunications.com 301-280-5756 Burness Communications 7 world-class cities riding tall in bike-share boom, solving 'the last mile' without cars ITDP issues first-ever planning guide to shape the next wave of bike-share systems; More than 400 ...

Feeding by tourists compromises health of already-endangered iguanas, study finds

2013-12-06
Feeding by tourists compromises health of already-endangered iguanas, study finds Feeding wildlife is an increasingly common tourist activity, but a new study published online today by the journal Conservation Physiology shows that already-imperilled iguanas ...

Eating healthy vs. unhealthy diet costs about $1.50 more per day

2013-12-06
Eating healthy vs. unhealthy diet costs about $1.50 more per day Meta-analysis pinpoints the price difference of consuming a healthy diet, which could be burden for low-income families but is trivial compared with health costs of eating an unhealthy diet Boston, ...

JILA team develops 'spinning trap' to measure electron roundness

2013-12-06
JILA team develops 'spinning trap' to measure electron roundness BOULDER, Colo. — JILA researchers have developed a method of spinning electric and magnetic fields around trapped molecular ions to measure whether the ions' tiny electrons are truly ...

UEA research gives first in-depth analysis of primate eating habits

2013-12-06
UEA research gives first in-depth analysis of primate eating habits From insect-munching tamarins to leaf-loving howler monkeys, researchers at the University of East Anglia (UEA) have compiled the most thorough review of primate eating habits to date. Findings ...

Stockings perform better than bandages to treat leg ulcers

2013-12-06
Stockings perform better than bandages to treat leg ulcers A new study has found that leg ulcers take the same time to heal when people wear compression stockings rather than traditional bandages A new study has found that leg ulcers take the ...

US stroke deaths declining due to improved prevention, treatment

2013-12-06
US stroke deaths declining due to improved prevention, treatment American Heart Association/American Stroke Association scientific statement Stroke deaths in the United States have declined dramatically in recent decades due to improved treatment and prevention, ...

Vaccine study reveals link between immunity and cells' starvation response

2013-12-06
Vaccine study reveals link between immunity and cells' starvation response What makes yellow fever vaccine especially effective One of the most effective vaccines in history has been the yellow fever vaccine, which was developed in the 1930s and has been administered ...

LAST 30 PRESS RELEASES:

University of Colorado Anschutz Medical Campus awarded one of the largest clinical trial grants in campus history to lead trauma study

Weather-tracking advances are revealing astonishing extremes of lightning

Grasses are spendthrifts, forests are budgeters, in a nuanced account of plant water use

"Scrumping" windfallen fruits and the origin of feasting

How ‘scrumping’ apes may have given us a taste for alcohol

Scrumped fruit key to chimpanzee life and a major force of human evolution

Scientists discover new quantum state at the intersection of exotic materials

Healthy food systems: Microbial map reveals countless hidden connections between our food, health, and planet

Microbiome breakthrough: Gut bacterium may hold key to future treatments for widespread chronic diseases

Turning biodiversity upside down: Conservation maps miss fungal hotspots by focusing on plants

AI at the core: philanthropy fuels EMBL’s strategy

Synthetic torpor has potential to redefine medicine

Are you eligible for a clinical trial? ChatGPT can find out

New treatment could reduce brain damage from stroke, study in mice shows

4,000-year-old teeth record the earliest traces of people chewing psychoactive betel nuts

Efficient solar harvesting even in high humidity

Heavy drinking raises the risk of undesired pregnancy; cannabis use does not

New study shows young adults who use high strength cannabis do not ‘titrate’ to less risky levels of use

Black hole vibes

Actual distance travelled by migrating whales drastically underestimated

The eagles resistant to poisonous toads

Cyberstalking growing at faster rate than other forms of stalking

CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity

Several healthy diet patterns are associated with reduced risk of type 2 diabetes regardless of ethnicity – shows meta-analysis of more than 800,000 people

Liver fibrosis to cancer: scientists map path to block deadly transition

Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors

Cancer's double agents: Fibroblasts both help and hinder immunotherapy

Unveiling large multimodal models in pulmonary CT: A comparative assessment of generative AI performance in lung cancer diagnostics

AI can fake peer reviews and escape detection, study finds

T cell senescence in the tumor microenvironment

[Press-News.org] Cancer's game of hide-and-seek
Researchers describe a novel mechanism by which glioblastoma tumors resist targeted therapies